A multivitamin is usually the first product a new brand asks for, because it sounds simple: put the common vitamins and minerals in one tablet. In Japan it is not simple, because there is no single “multivitamin” entry in the country’s labelling system — each nutrient in the formula stands on its own.
This guide is for brand owners planning a Japan-made multivitamin (often multivitamin plus mineral) product. It covers what the largest human trials of multivitamin supplementation actually found, how Japan’s labelling system treats a multi-nutrient formula nutrient by nutrient, how such a product is usually formulated, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a multivitamin product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Two of the largest multivitamin trials ever run found real but modest benefits — slower cognitive decline in older adults in one, a lower total cancer rate in well-nourished male physicians in the other — with no effect on the outcomes that mattered most (cardiovascular disease, all-cause mortality, or actually preventing cognitive impairment).
| Study | Design | Reported result |
|---|---|---|
| COSMOS trial, Baker LD et al, Alzheimer’s & Dementia 2023;19(4):1308-1319 (PMID 36102337) | Randomised, placebo-controlled, 2×2 factorial trial; daily multivitamin-mineral (MVM) and/or cocoa extract for 3 years; 2,262 US adults aged 65+ | Cocoa extract had no effect on global cognition (mean z = 0.03, P = .28); MVM produced a statistically significant benefit on global cognition (mean z = 0.07, 95% CI 0.02–0.12, P = .007), most pronounced in participants with a history of cardiovascular disease |
| COSMOS cognitive meta-analysis, Vyas CM et al, American Journal of Clinical Nutrition 2024;119(3):692-701 (PMID 38244989) | Pooled analysis of 3 COSMOS cognitive sub-studies (clinic, telephone and web-based testing), 5,203 participants total | MVM showed a modest benefit in the clinic subcohort (573 participants; global cognition +0.06 SD, episodic memory +0.12 SD over 2 years); across all three sub-studies, “clear evidence of MVM benefits” on global cognition (P = 0.0009), described by the authors as equivalent to reducing cognitive ageing by about 2 years |
| COSMOS-Mind incidence analysis, Sachs BC et al, Alzheimer’s & Dementia 2023;19(11):4863-4871 (PMID 37035889) | Same trial population, 3-year adjudicated incidence of mild cognitive impairment (MCI) and dementia; 110 incident MCI cases, 14 incident dementia cases | MVM did not significantly reduce the incidence of MCI or dementia (all p ≥ 0.05); participants who took MVM and still converted to MCI had better global cognition and executive-function scores, and had declined less, than placebo converters |
| Physicians’ Health Study II, Gaziano JM et al, JAMA 2012;308(18):1871-1880 (PMID 23162860) | Randomised, double-blind, placebo-controlled trial; daily multivitamin for a median 11.2 years; 14,641 US male physicians, mean age 64.3 at entry | Modest but statistically significant reduction in total cancer incidence (17.0 vs 18.3 events per 1,000 person-years); no significant reduction in prostate or colorectal cancer specifically, cancer mortality, cardiovascular events, or all-cause mortality |
Four points worth holding onto:
- “Modest” is the accurate word, not “proven.” The COSMOS cognition effect and the PHS II cancer effect are both real, statistically significant, and small. Neither trial found a broad disease-prevention or mortality benefit, and COSMOS-Mind’s own separate incidence analysis found no significant reduction in actually developing MCI or dementia.
- Population matters. PHS II studied well-nourished US male physicians aged 50 and over — a population unlikely to be short of most nutrients from diet alone. Results may not generalise to other populations, including younger adults, women, or people in nutrient-poor diets.
- Funding is mixed and disclosed. COSMOS was primarily funded by the US National Institute on Aging and the Alzheimer’s Association; several COSMOS investigators also disclosed research support from Mars Edge (a maker of the cocoa extract tested in the trial) and Pfizer Consumer Healthcare. That does not invalidate the findings, but it belongs in any honest summary.
- The US Preventive Services Task Force has not endorsed multivitamins for disease prevention in the general population. Its formal conclusion: “the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer” (an “I statement” — insufficient evidence, not a recommendation for or against).
Checked against the published abstracts on 25 September 2026.
What Japanese products say
There is no single “multivitamin” entry in Japan’s labelling system — a multivitamin product can notify under Foods with Nutrient Function Claims for several nutrients at once, but every one of those nutrients must independently fall within its own fixed daily-amount range and carry its own fixed, unmodifiable wording. There is no combined or averaged claim.
Under this system (栄養機能食品), a business can label a food with a nutrient function claim without individual government pre-review, provided the notified daily amount for that nutrient sits inside a fixed range and the label uses only the exact wording the Consumer Affairs Agency (CAA) has set. For a multi-nutrient product, this check has to be run nutrient by nutrient. The CAA’s Food Labeling Standards (食品表示基準 別表第11), as published in the CAA’s April 2025 reference document, set the following ranges for nutrients most commonly found in a multivitamin:
| Nutrient | Notified daily amount (lower–upper) | Function claim (fixed wording, cannot be reworded) |
|---|---|---|
| Vitamin A | 231–600 µg | ”Vitamin A is a nutrient that helps maintain vision in dim light and helps maintain the health of skin and mucous membranes.” Extra caution: women who are or may be pregnant, within the first 3 months, should be careful to avoid excessive intake |
| Vitamin B1 | 0.36–25 mg | Function wording set separately per B vitamin in the same reference document |
| Vitamin B2 | 0.42–12 mg | as above |
| Vitamin B6 | 0.39–10 mg | as above |
| Vitamin B12 | 0.72–60 µg | as above |
| Niacin | 3.9–60 mg | as above |
| Pantothenic acid | 1.44–30 mg | as above |
| Biotin | 15–500 µg | as above |
| Folic acid | 72–200 µg | as above, plus a mandatory extra caution that it does not further improve fetal development at high intakes |
| Vitamin C | 30–1,000 mg | ”Vitamin C is a nutrient that helps maintain the health of skin and mucous membranes, and has antioxidant properties.” |
| Vitamin D | 1.65–5.0 µg | ”Vitamin D is a nutrient that promotes the absorption of calcium in the intestine and helps in the formation of bone.” |
| Vitamin E | 1.89–150 mg | Function wording set separately in the same reference document |
| Vitamin K | 45–150 µg | as above, plus a mandatory extra caution that people on anticoagulant/blood-thinning medication should avoid this product |
| Calcium | 204–600 mg | Function wording set separately in the same reference document |
| Iron | 2.04–10 mg | as above |
| Zinc | 2.64–15 mg | as above, plus a mandatory extra caution that zinc may inhibit copper absorption at excess intake |
| Magnesium | 96–300 mg | as above, plus a mandatory extra caution that excess intake may cause loose stools |
| Copper | 0.27–6.0 mg | as above |
| Potassium | 840–2,800 mg | as above, plus a mandatory extra caution that people with reduced kidney function should avoid this product |
Every notified product, whichever nutrients it covers, must also carry the standard caution wording — “This product does not cure disease or further promote health through excessive intake. Follow the daily recommended amount” — and the standard disclosure that, unlike Foods for Specified Health Uses, it has not been individually reviewed by the Commissioner of the Consumer Affairs Agency (Source: Consumer Affairs Agency, “Foods with Nutrient Function Claims” reference document, dated April 2025, 食品表示基準 別表第11).
Three points worth being precise about:
- These ranges are labelling ceilings for the notified amount, not medical safety limits. They are not the same as a Tolerable Upper Intake Level used in nutrition science, and they should not be described as a safety threshold in your own marketing.
- This is a self-certification system with fixed wording per nutrient, not a system a brand can adapt into one combined “multivitamin story.” Every nutrient you notify for needs its own individual check against its own range, and carries only its own fixed sentence — there is no shortcut for a multi-nutrient product.
- A Japanese notification is a Japanese labelling mechanism. It has no legal standing outside Japan. In the EU, for example, a multivitamin typically relies on the same per-nutrient authorised claims already listed in the EU Register of nutrition and health claims for each individual vitamin and mineral — the register explicitly treats “health claims for combinations of substances” as a separate matter from claims “already authorised for some of the individual substances,” rather than granting one combined multivitamin claim.
💬 Need an evidence summary for your regulatory adviser that checks every nutrient in your formula against its own Japanese range and function wording? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe a multivitamin by what was studied and in which population, never as a blanket health-improvement or disease-prevention product.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains [list] vitamins and minerals at [amount] per serving" | "Prevents disease”, “boosts overall health”, or any claim implying the COSMOS or PHS II results apply broadly |
| ”Studied for cognitive function in older adults” (citing the actual trial and its modest effect size) | Implying a multivitamin reduces the risk of developing dementia or cognitive impairment — the same trial found no significant effect on that outcome |
| ”Studied for cancer incidence in a trial of older adult men” | Implying protection against cardiovascular disease or death — PHS II found no effect on either |
| Naming the specific nutrient function claim you notify for in Japan, exactly as the CAA wording states | A single combined “multivitamin” claim — Japan’s system does not have one |
How multivitamin is formulated
Because a multivitamin combines many nutrients at once, the central formulation task is not choosing one dosage form — it is checking every single nutrient, individually, against its own labelling range, its own upper safety limit, and its own regulatory wording in each target market.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet | Compact, low cost per serving, familiar format | Fill volume limits how many nutrients and how much of each can fit |
| Hard capsule | Flavourless, easy to combine actives | Similar fill-volume limits to tablets |
| Powder stick or sachet | Higher fill volume, suits larger mineral doses (e.g. calcium, magnesium) | Taste masking, moisture protection |
| Two-part or layered tablet | Separates nutrients that are unstable together (e.g. certain minerals and vitamins) | Higher manufacturing cost and complexity |
Decisions that shape the specification:
- Check every nutrient individually, twice. For each vitamin and mineral in the formula: confirm it sits within its Japanese Nutrient Function Claims range if you intend to notify it (see the table above), and separately confirm it sits below its Tolerable Upper Intake Level for your target market — the two figures are different and neither substitutes for the other. Combining several nutrients that are each close to their individual upper limit needs careful formulation, not just a total-weight check.
- Fill volume is the real constraint. A tablet or capsule can only hold so much. Gram-level minerals such as calcium and magnesium often force a powder stick, a larger tablet, or dropping one of them from the formula — decide this early, not after the spec is fixed.
- A small number of nutrients carry a genuine, well-documented excess risk. Preformed vitamin A in early pregnancy is linked to birth defects when intake is excessive (Abadie RB et al, Cureus 2023;15(12):e50513, PMID 38226115), which is why Japan’s own vitamin A notification carries a specific pregnancy caution. Iron is one of the leading causes of paediatric poisoning deaths in the United States, largely from adult-strength iron products rather than children’s chewable vitamins (Anderson BD et al, Journal of Emergency Medicine 2000;19(3):255-258, PMID 11033271) — child-resistant packaging and a conservative iron level matter if the product may reach a household with young children.
- Companion and format choices. Some multivitamins add botanical extracts for an “energy” or “immunity” story. Every such ingredient needs its own separate check against Japanese food law — a formula that works nutrient-by-nutrient for its vitamins and minerals can still fail because of one added herb.
- Which nutrients you actually notify. You do not have to notify every nutrient in the formula under Japan’s Nutrient Function Claims system — only nutrients within their range, with their exact wording, should be claimed. A nutrient present in the formula but outside its notifiable range, or one you choose not to claim, is simply listed as an ingredient without a function statement.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product — and in a multivitamin, that check has to run once per nutrient and once per companion ingredient, not once for the whole product.
The individual vitamins and minerals covered above are all routine food and supplement ingredients in Japan. The risk in a multivitamin formula usually comes from added botanical extracts, or from a nutrient amount that does not sit in the Japanese notifiable range even though it is legal to include as an ingredient. See the Japan-made supplement OEM page, and our vitamin D and vitamin C guides for the single-nutrient detail behind two of the nutrients most often included in a multivitamin.
Before you ask for a quotation
A factory can quote accurately once every nutrient’s amount, the dosage form and the packaging are fixed.
- Full nutrient list with the amount of each per serving
- Which nutrients, if any, you intend to notify under Japan’s Nutrient Function Claims system
- Dosage form (tablet, capsule, powder stick)
- Companion ingredients beyond standard vitamins and minerals, and their amounts
- Packaging, including child-resistant packaging if the formula contains iron or other nutrients with a known overdose risk
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made multivitamin? Send us the concept — the full nutrient list, amounts, dosage form and the countries you will sell in.
Frequently asked questions
1. Is there a single “multivitamin” claim in Japan?
No. Japan’s Foods with Nutrient Function Claims system has no combined or averaged multivitamin entry. A product can notify for several nutrients at once, but every nutrient must independently fall within its own fixed daily-amount range and carry its own fixed, unmodifiable wording.
2. Does a multivitamin actually work?
The evidence is mixed and modest, not proven and broad. A large US trial (COSMOS) found a statistically significant but modest benefit on cognitive decline in older adults, and a separate large trial (Physicians’ Health Study II) found a modest reduction in total cancer incidence in older male physicians, with no effect on cardiovascular disease or death in either trial. The US Preventive Services Task Force has said the evidence is insufficient to recommend multivitamins for disease prevention in the general population.
3. What is the difference between Japan’s notified amount range and a safety upper limit?
The Japanese ranges in the table above are labelling ceilings for what a product may notify — they describe what a business can put on a label under the self-certification system, not the outer medical safety limit. A nutrient’s Tolerable Upper Intake Level is a separate figure from nutrition science and should be checked independently for your target market.
4. Which nutrients need extra caution in a multivitamin formula?
Under Japan’s system, vitamin A carries a pregnancy caution, folic acid carries a caution about fetal development at high intakes, vitamin K carries a caution for people on blood-thinning medication, zinc and magnesium carry excess-intake cautions, and potassium carries a caution for reduced kidney function. Separately, excess preformed vitamin A in early pregnancy and accidental iron overdose in young children are well-documented risks worth designing around regardless of which country you sell in.
5. Can I fit every common vitamin and mineral into one tablet?
Not always. Fill volume is usually the real constraint, not any single nutrient’s chemistry. Gram-level minerals such as calcium and magnesium often push the format toward a larger tablet, a powder stick, or dropping one nutrient from the formula — decide this before the spec is fixed.
Sources: “Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial”, Baker LD et al, Alzheimer’s & Dementia 2023;19(4):1308-1319 (PMID 36102337); “Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of COSMOS and meta-analysis of 3 cognitive studies within COSMOS”, Vyas CM et al, American Journal of Clinical Nutrition 2024;119(3):692-701 (PMID 38244989); “Impact of multivitamin-mineral and cocoa extract on incidence of mild cognitive impairment and dementia: Results from COSMOS-Mind”, Sachs BC et al, Alzheimer’s & Dementia 2023;19(11):4863-4871 (PMID 37035889); “Multivitamins in the Prevention of Cancer in Men: The Physicians’ Health Study II Randomized Controlled Trial”, Gaziano JM et al, JAMA 2012;308(18):1871-1880 (PMID 23162860); US Preventive Services Task Force, “Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication” recommendation statement; “Vitamin A-Mediated Birth Defects: A Narrative Review”, Abadie RB et al, Cureus 2023;15(12):e50513 (PMID 38226115); “Retrospective analysis of ingestions of iron containing products in the United States: are there differences between chewable vitamins and adult preparations?”, Anderson BD et al, Journal of Emergency Medicine 2000;19(3):255-258 (PMID 11033271); EU Register of nutrition and health claims made on foods, European Commission; Consumer Affairs Agency, “Foods with Nutrient Function Claims” reference document, dated April 2025 (食品表示基準 別表第11), caa.go.jp. Checked on 25 September 2026.